William Blair Decreases Earnings Estimates for FibroGen
FibroGen, Inc. (NASDAQ:FGEN – Free Report) – Equities researchers at William Blair lowered their FY2025 EPS estimates for shares of FibroGen in a report issued on Tuesday, May 13th. William Blair analyst A. Hsieh now expects that the biopharmaceutical company will earn ($1.04) per share for the year, down from their prior estimate of ($0.88). […]
FibroGen, Inc. (NASDAQ:FGEN – Free Report) – Equities researchers at William Blair lowered their FY2025 EPS estimates for shares of FibroGen in a report issued on Tuesday, May 13th. William Blair analyst A. Hsieh now expects that the biopharmaceutical company will earn ($1.04) per share for the year, down from their prior estimate of ($0.88). […]
